hexamethylene bisacetamide has been researched along with glycolipids in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, PW; Fenderson, BA; Hakomori, S; Nudelman, E | 1 |
Gubler, ML; Maffei, L; McCue, PA; Sherman, MI | 1 |
2 other study(ies) available for hexamethylene bisacetamide and glycolipids
Article | Year |
---|---|
Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxyuridine (BUdR).
Topics: Acetamides; Antibodies, Monoclonal; Antibody Specificity; Antigens, Neoplasm; Antigens, Surface; Biomarkers, Tumor; Bromodeoxyuridine; Cell Membrane; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Glycolipids; Humans; Membrane Lipids; Retinoids; Teratoma; Tumor Cells, Cultured | 1990 |
Complementation analyses of differentiation-defective embryonal carcinoma cells.
Topics: Acetamides; Animals; Antigens, Surface; Carrier Proteins; Cell Differentiation; Cell Line; Embryonal Carcinoma Stem Cells; Glycolipids; Hybrid Cells; Lewis X Antigen; Male; Mice; Mutation; Neoplastic Stem Cells; Plasminogen Activators; Receptors, Retinoic Acid; Stem Cells; Teratoma; Tretinoin | 1984 |